CN1229126C - Chinese medicine for curing rheumatoid arthritis - Google Patents

Chinese medicine for curing rheumatoid arthritis Download PDF

Info

Publication number
CN1229126C
CN1229126C CN 02137816 CN02137816A CN1229126C CN 1229126 C CN1229126 C CN 1229126C CN 02137816 CN02137816 CN 02137816 CN 02137816 A CN02137816 A CN 02137816A CN 1229126 C CN1229126 C CN 1229126C
Authority
CN
China
Prior art keywords
medicine
patients
chinese medicine
taking
cured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 02137816
Other languages
Chinese (zh)
Other versions
CN1394642A (en
Inventor
宣安国
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02137816 priority Critical patent/CN1229126C/en
Publication of CN1394642A publication Critical patent/CN1394642A/en
Application granted granted Critical
Publication of CN1229126C publication Critical patent/CN1229126C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a Chinese medicine for curing rheumatoid arthritis, which is prepared by machining 11 kinds of medicines comprising Indian bread pink epidermis, Chinese angelica, broom cypress fruit, acanthopanax bark, coralbean bark, loquat leaf, swallowwort root, scutellaria root, patchouli, rhizoma coptidis from Sichuan of China, and akebia stem, into liquid medicine or pills or granules or capsules for patients to take. The Chinese medicine has over 95% effective rate and cure rate over 90% to patients in the rheumatoid arthritis. The patients with a short disease course and a light disease state can be cured by taking the medicine for 15 to 20 days; the patients with a long disease course and the redness and the swelling of partial small joints can be cured by taking the medicine for two months; the patients with a serious disease state and redness and swelling of partial big joints can be cured by taking the medicine for three months; and diseases are free from relapse once cured. The Chinese medicine has poor therapeutic effects on patients in adrenocortical atrophy caused by taking hormone medicine for a long time.

Description

A kind of Chinese medicine for the treatment of rheumatoid arthritis
(1), technical field
The present invention relates to a kind of Chinese medicine composition, the arthritic Chinese medicine of specifically a kind of treatment atrophic.
(2), background technology
Rheumatoid arthritis belongs to a kind of rheumatism disease of immune system, " damp is greasy to stagnate, and touching difficulty more ", it is global difficult and complicated illness, the course of disease is long, and state of an illness complexity often causes internal organs and neural variations such as skeleton, muscle, cardiopulmonary Liver and kidney and causes joint deformity, disables etc.Anti-inflammation class effect of drugs commonly used in the Western medicine is not good, and hormone medicine has side effect more, even causes new iatrogenic disease.The disclosed a kind of red and swollen heat pain compound capsule that rheumatoid causes for the treatment of of CN1064533C is made up of betamethasone, Pyridoxine Hydrochloride, Hydrochlorothiazide and the mixing of three aminopterin; The disclosed a kind of treatment rheumatoid pure Chinese medicine capsule of CN1057001C is made up of Semen Strychni (processed), Flos Daturae and Pyritum (calcined); The capsule that CN1060339C disclosed control rheumatoid disease inflammation and bone become is made up of Arechin (Polfa) and Pulvis Fellis Suis; CN1063046C is disclosed to treat rheumatoid capsule to regulate immunologic function, is made up of levamisole hydrochloride and Pulvis Fellis Suis; The rheumatoid micronutrient element capsule of the disclosed treatment of CN1063041C is made up of zinc gluconate and ferric ammonium citrate.
(3), summary of the invention
Theory of Chinese medical science is thought, wind, cold, wet three gas close and are numbness, real pathogeny is that exogenous cold causes the skin heat sinking function and goes down, destroyed the coordinated balance relation between the internal organs, make real person's benefit real, empty person's benefit is empty, and QI and blood is not smooth, passages through which vital energy circulates is obstructed, and the muscles and bones joint must not be moistened and be supported and erosion wound (this dirty piece of writing of Miraculous Pivot, the gas piece of writing of determining).The applicant constantly explored through two more than ten years, was purport to transfer internal organs, smooth QI and blood, battalion's negative and positive to strengthen metabolism, the following percentage by weight of combination ten simply Chinese medicine be processed into certain preparation for patient's use, obtained good curative effect.
Poria 12%,
Radix Angelicae Sinensis 12%,
The Fructus Kochiae 12%,
Cortex Acanthopancis 10%,
Folium Eriobotryae 10%,
Cortex erythrinae 9%,
Radix Cynanchi Atrati 9%,
Radix Scutellariae 8%,
Rhizoma Coptidis 7%,
Herba Pogostemonis 6%,
Caulis Akebiae 5%.
More than 95%, cure rate is more than 90% to the patient with rheumatoid arthritis obvious effective rate for this Chinese medicine.The patient shorter to the course of disease, that the state of an illness is lighter takes medicine and can cure in 15~20 days; Longer to the course of disease, the patient of the little redness and swelling of joints of part appears, and take medicine and can cure in two months; Heavier to the state of an illness, as big redness and swelling of joints to occur patient takes medicine and can cure in three months.Healing person is no longer recurred.But, cause patient's curative effect of adrenal cortex atrophy relatively poor to taking hormone medicine for a long time.
(4), the specific embodiment
Be example with patient's one daily dose now, preparations such as decoction, pill are described below.
1, decoction
Get Radix Angelicae Sinensis, each 12g of the Fructus Kochiae, Cortex Acanthopancis, each 10g of Folium Eriobotryae, Cortex erythrinae, each 9g of Radix Cynanchi Atrati, Radix Scutellariae 8g, Rhizoma Coptidis 7g, Herba Pogostemonis 6g, Caulis Akebiae 5g will add 150~200ml water after the above-mentioned ten flavor medicines mixing, decoct postcooling, filtration in 15~20 minutes and obtain decoction, three parts of five equilibriums add 4g Poria powder and stir evenly in every portion of soup, early, middle and lately respectively obey potion.Decoction needs decoct every day, and also inconvenience is stored and carried.
2, pill
Dosage and method as embodiment 1 make soup, concentrate then to be extractum, add 12g Poria powder again and mix thoroughly; at this moment the Poria powder also plays excipient, makes extractum become cream mud shape, about about 30g; be reprocessed into the granule ball,, divide to take for early, middle and late three times such as 90 or 120 etc.Pill is convenient to store taking convenience.
3, electuary or capsule
Dosage and method as embodiment 1 make soup, and spray drying obtains dry powder then, with 12g Poria powder mix homogeneously, promptly are electuaries, or promptly are capsule in incapsulating again, divide to take for early, middle and late three times.

Claims (1)

1, a kind of Chinese medicine for the treatment of rheumatoid arthritis is to select for use Chinese medicine to be processed into decoction, pill, electuary or capsule, and it is characterized in that: described Chinese medicine and percentage by weight thereof are
Poria 12%, Radix Angelicae Sinensis 12%,
The Fructus Kochiae 12%, Cortex Acanthopancis 10%,
Folium Eriobotryae 10%, Cortex erythrinae 9%,
Radix Cynanchi Atrati 9%, Radix Scutellariae 8%,
Rhizoma Coptidis 7%, Herba Pogostemonis 6%,
Caulis Akebiae 5%.
CN 02137816 2002-06-18 2002-06-18 Chinese medicine for curing rheumatoid arthritis Expired - Fee Related CN1229126C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02137816 CN1229126C (en) 2002-06-18 2002-06-18 Chinese medicine for curing rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02137816 CN1229126C (en) 2002-06-18 2002-06-18 Chinese medicine for curing rheumatoid arthritis

Publications (2)

Publication Number Publication Date
CN1394642A CN1394642A (en) 2003-02-05
CN1229126C true CN1229126C (en) 2005-11-30

Family

ID=4749125

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02137816 Expired - Fee Related CN1229126C (en) 2002-06-18 2002-06-18 Chinese medicine for curing rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN1229126C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102397356B (en) * 2010-09-15 2014-03-12 邓颖 Medicinal composition for treating rheumatoid arthritis and preparation method thereof
CN102949620B (en) * 2012-09-25 2014-09-24 王鹏先 Traditional Chinese medicine composition for treating paralysis

Also Published As

Publication number Publication date
CN1394642A (en) 2003-02-05

Similar Documents

Publication Publication Date Title
CN1148211C (en) Medicine for treating congestive heart failure
CN103768537B (en) Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris
CN1319414A (en) Medicine for treating hecrosis of femoral head
CN103784820A (en) Traditional Chinese medicine formula for treating cariac blood stasis type coronary heart disease
CN103330805B (en) Traditional Chinese medicine composition for treating menorrhagia
CN103341079B (en) Chinese medicine composition for treating acne
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN103055116A (en) Traditional Chinese medicine composition for treating acnes
CN1931329A (en) Stomatocase treating medicine
CN104740583B (en) It is a kind of to be used to alleviate Chinese medicine preparation of Crohn disease and preparation method thereof
CN102988616B (en) Chinese medicinal composition for treating anemia
CN1317021C (en) Chinese medicinal formulation for stopping pain for removing Bi
CN106729379A (en) It is a kind of to treat Externally applied Chinese medicine powder of acute gouty arthritis and preparation method thereof
CN103479768A (en) Composite traditional Chinese medicine compound for treating chronic lymphocytic thyroiditis
CN106539882A (en) Traditional Chinese medicine composition for foot bath and preparation method thereof
CN1229126C (en) Chinese medicine for curing rheumatoid arthritis
CN101966305A (en) Traditional Chinese medicine for treating dental ulcer
CN105412899A (en) Traditional Chinese medicine preparation for relieving erythromelalgia and preparation method thereof
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN104225507A (en) Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage
CN111973714A (en) Traditional Chinese medicine composition and pill for treating rheumatism as well as preparation method and application of traditional Chinese medicine composition and pill
CN104587131A (en) Traditional Chinese medicinal composition for treating delayed menorrhea
CN104606471A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN103705898A (en) Traditional Chinese medicine composition for treating acnes
CN102614420A (en) Chinese medicine preparation for curing atrophic glossitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee